Clinical characteristics in hypertension and non-hypertension groups

CharacteristicsNon-hypertension (N = 1,347)Hypertension (N = 1,309)P value
Age (year)58.73 ± 8.3263.72 ± 9.85< 0.001
Male (%)34.9741.63< 0.001
Diabetes mellitus (%)14.4831.17< 0.001
Coronary artery disease (%)7.8727.35< 0.001
Smoking (%)15.6617.80< 0.001
Stroke (%)4.8319.10< 0.001
Calcium channel blocker (%)0.4544.69< 0.001
Angiotensin-converting enzyme inhibitors (%)0.457.56< 0.001
Angiotensin II receptor blocker (%)0.3029.34< 0.001
Beta blockers (%)2.8218.03< 0.001
Glycosidase inhibitors (%)6.0911.84< 0.001
Metformin (%)5.6410.85< 0.001
Sulfonylureas (%)2.675.040.001
Insulin (%)2.383.970.019
Statins (%)15.5933.16< 0.001
Waist circumference (cm)83.03 ± 9.0887.46 ± 9.35< 0.001
Hip circumference (cm)95.84 ± 7.1198.47 ± 7.77< 0.001
BMI (kg/m2)24.50 ± 3.3226.00 ± 6.20< 0.001
CAVI8.27 ± 1.178.73 ± 1.42< 0.001
SBP (mmHg)127.93 ± 14.65141.06 ± 17.77< 0.001
DBP (mmHg)80.75 ± 13.3786.30 ± 11.82< 0.001
Creatinine (μmol/L)64.83 ± 14.5970.14 ± 29.70< 0.001
FPG (mmol/L)5.99 ± 2.106.27 ± 1.88< 0.001
UA (μmol/L)315.64 ± 116.52340.76 ± 176.37< 0.001
TC (mmol/L)5.34 ± 1.104.86 ± 1.17< 0.001
HDL-C (mmol/L)1.40 ± 0.341.26 ± 0.43< 0.001
LDL-C (mmol/L)3.03 ± 0.902.76 ± 0.84< 0.001
TG/HDL-C ratio1.36 ± 1.531.73 ± 5.09< 0.001
hs-CRP (mg/L)3.12 ± 7.102.08 ± 4.19< 0.001
Homocysteine (μmol/L)11.77 ± 6.4913.74 ± 7.19< 0.001
HbA1c (%)5.74 ± 1.066.06 ± 1.20< 0.001
TG (mmol/L)1.70 ± 1.341.97 ± 7.220.005

Comparisons between the two groups were analyzed by t-test, and the Wilcoxon-Mann-Whitney test was used for non-normally distributed data (hs-CRP, TG/HDL-C ratio, TG). Proportions were analyzed by χ2-test. BMI: body mass index; CAVI: cardio-ankle vascular index; DBP: diastolic blood pressure; FPG: fasting plasma glucose; HDL-C: high-density lipoprotein cholesterol; hs-CRP: hypersensitive C-reactive protein; LDL-C: low-density lipoprotein cholesterol; SBP: systolic blood pressure; TC: total cholesterol; TG: triglycerides; UA: uric acid